News
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
Industry insiders often have perspectives that are invaluable for investors to learn. In that vein, AstraZeneca's (NASDAQ: AZN) CEO, Pascal Soriot, recently made some interesting remarks during the
Eli Lilly's Obesity Drug Shows a Heart Benefit. Is It Time to Buy?
Shares of Eli Lilly (NYSE: LLY) notched a 3.5% gain on Thursday, Aug. 1, after the company reported positive clinical trial results for its increasingly successful weight management treatment. It
3 Unstoppable Stocks to Buy in August
What are the best stocks? Usually, the ones that have clear paths to success.
Three Motley Fool contributors have identified what they believe are unstoppable stocks to buy in August. And they all
Is Regeneron Pharmaceuticals Due for a Stock Split?
Regeneron Pharmaceuticals (NASDAQ: REGN) stock is trading above the $1,000 mark. It's at a high enough threshold that the company could decide to split its stock. That would lower the share price
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
There are plenty of excellent reasons to invest in dividend stocks, including the fact that only rock-solid companies can afford to sustain payout increases for a long time. When you put your money
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
Few healthcare companies are more famous than Johnson & Johnson (NYSE: JNJ). The pharmaceutical giant earned its stature in the industry thanks to its incredible innovative abilities and a business
Where Will Novavax Be in 5 Years?
Five years ago, Novavax (NASDAQ: NVAX) was a little-known clinical-stage biotech whose leading pipeline candidate was an influenza vaccine. Then came the pandemic. The company quickly grew in
Is This Decision by Pfizer Bad News for Eli Lilly?
Eli Lilly (NYSE: LLY) stock has soared by double digits over the past year -- and for good reason. The pharma giant sells two of the most sought-after drugs today, weight loss treatments Mounjaro
Wall Street Collapses but Verizon, T-Mobile, and AT&T Rise. Here's Why
The stock market had a terrible end to the week, and very few companies were spared from the carnage. Three that were up are in the telecom industry and probably aren't on your list of top stocks
Why Did Nvidia, Intel, AMD, and Arm Crash on Thursday?
In this video, I will explain why semiconductor stocks like Nvidia (NASDAQ: NVDA), Intel, Arm Holdings, and Advanced Micro Devices all crashed on Thursday and talk about whether this presents a
Prediction: This Could Be Amgen's Next Massive Growth Opportunity
The biotech Amgen (NASDAQ: AMGN) isn't exactly known as a growth stock. Over the past few years, the company's organic revenue hasn't been increasing at a particularly impressive rate. The drugmaker
Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.
Vertex Pharmaceuticals (NASDAQ: VRTX) has churned out nice profits quarter after quarter for years. The big biopharmaceutical company's cystic fibrosis (CF) franchise made it easy.
However, Vertex
Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth
Johnson & Johnson (NYSE: JNJ) is one of the top healthcare companies in the world. Last year, it spun off its consumer health business to focus on growing other parts of its operations, which
Is Pfizer Winning Its $43 Billion Bet?
Pfizer (NYSE: PFE) is one of the most successful pharmaceutical companies ever. In 2022, it brought in more than $100 billion in revenue -- a record for itself and for the entire industry. Of
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2024 Earnings CallAug 01, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Nvidia Stock Sank Today -- Is It Time to Buy the Dip?
Volatility continued for Nvidia (NASDAQ: NVDA) stock in Thursday's trading. The artificial intelligence (AI) leader's share ended the daily session down 6.7%, according to data from S&P Global
Biogen (BIIB) Q2 2024 Earnings Call Transcript
Cigna Group (CI) Q2 2024 Earnings Call Transcript
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
Great companies can deliver meaningful portfolio growth in a wide range of economic and market environments. From established companies to emerging businesses, the types of stocks you favor will
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
Pfizer (NYSE: PFE) has been a nightmare for many investors in recent years. At one point earlier this year, the big pharma stock was nearly 60% below its peak set in late 2021.
However, the
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
Investors who buy stocks through both bull and bear markets are the ones who tend to benefit more in the long term because they are growing their portfolios consistently. But a bull market does seem
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
The anti-obesity drug market could be worth a staggering $100 billion, according to some analysts. That's a huge growth opportunity, and it's a reason why many top drugmakers in the world are
Pfizer Just Did This for the First Time in 6 Quarters. Time to Buy?
Just a couple of years ago, Pfizer's (NYSE: PFE) revenue was soaring thanks to sales of its coronavirus vaccine. In fact, the vaccine became the world's best-selling pharmaceutical product and even
Why Vertiv Holdings, Constellation Energy, and NuScale Power Surged Higher Today
Shares of data center infrastructure company Vertiv Holdings (NYSE: VRT), as well as nuclear power-oriented companies Constellation Energy (NASDAQ: CEG) and NuScale Power (NYSE: SMR) were rallying